Clinical trial

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

NCT00002162

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Saquinavir Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Lamivudine Normalized identity: lamivudineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Stavudine Normalized identity: stavudineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Zidovudine Normalized identity: zidovudineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Zalcitabine Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Didanosine Normalized identity: didanosineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE2

Conditions

HIV Infectionsunresolved

Interventions

SaquinavirDRUG

LamivudineDRUG · verified · RxNorm: lamivudine

StavudineDRUG · verified · RxNorm: stavudine

ZidovudineDRUG · verified · RxNorm: zidovudine

ZalcitabineDRUG

DidanosineDRUG · verified · RxNorm: didanosine

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Mapped research locations

New YorkNew York, United States2 BostonMassachusetts, United States2 ChicagoIllinois, United States2 San FranciscoCalifornia, United States2 HoustonTexas, United States1 Los AngelesCalifornia, United States1 PhiladelphiaPennsylvania, United States1 AtlantaGeorgia, United States1 MiamiFlorida, United States1 San DiegoCalifornia, United States1 TampaFlorida, United States1 MontrealQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00002162 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.